top of page

Feb 24-25th 2021, online

ISNTD d³ 2021

Drug discovery & development, diagnostics and vaccines for tropical diseases

ISNTD d³ 2021: HEALTHY SYSTEMS, HEALTHY LIVES 

From diagnosis to treatment - from treatment to surveillance, elimination and global goals 

​

ISNTD d³ 2021 addresses the current gaps and collaboration opportunities across malaria, neglected tropical diseases and diseases of poverty to accelerate drug discovery & development, vaccine R&D and uptake, and diagnostics and surveillance opportunities.

 

This year, ISNTD d³ will focus on recent developments, gaps and future needs of drug discovery, treatments and diagnostics in context of global health as well as broader challenges.

​

Presentations & panel discussions will run on both days, and partnership meetings can be arranged throughout the day.

​

Workshops on focused technologies and skills run concurrently throughout both days.

 

Please contact krafiq@isntd.org for further details including speaking & attending and to become a conference sponsor.

​

​

Day 1: Feb 24th 2021

Drug Discovery & Development

Introduction: challenges in tropical disease control - from pipeline gaps to surveillance needs

​

Session 1 - Pipeline gaps: advancing treatment for diseases of poverty

 

Session 2 - Platforms and Tools

 

Session 3 - Open innovation: next steps for open collaboration in neglected disease drug discovery 

 

Session 4 - Disease specific sessions & Clinical trials session

 

Concluding remarks

​

Day 2: Feb 25th 2021

Diagnostics

Session 1: Collaboration in malaria & tropical diseases: developing surveillance & diagnosis to accelerate advocacy, funding & disease control

​

Session 2: Connectivity, technology and innovative diagnostics & disease focus workshops

​

Session 3: Diagnostics, surveillance and WHO targets: the role of diagnostics in the end-game

 

Concluding panel

Petra Van-Sloun (Merck Performance Materials): Insect repellents & regulatory hurdles in the EU
11:45
The International Society for Neglected Tropical Diseases

Petra Van-Sloun (Merck Performance Materials): Insect repellents & regulatory hurdles in the EU

At the annual ISNTD Bites conference, Petra Van Sloun from Merck Performance Materials speaks about current research and products at Merck for insect repellents, as well as the challenges posed by the regulatory framework in the EU for this field.
Pr. Gabriella Gibson (University of Greenwich): Vector behaviour & control and surveillance
20:52
The International Society for Neglected Tropical Diseases

Pr. Gabriella Gibson (University of Greenwich): Vector behaviour & control and surveillance

At the annual ISNTD Bites conference on vector-borne diseases and vector control, Pr. Gabriella Gibson from the University of Greenwich speaks about the importance of understanding the behaviour of vectors to improve the control and surveillance of vectors. The presentation focuses on the tse-tse fly and mosquitoes. Recorded at ISNTD Bites 2017 on July 19th at the Institute of Child Health, London.
bottom of page